Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis

Gian Marco Ghiggeri, Luca Musante, Giovanni Candiano, Maurizio Bruschi, Laura Santucci, Giancarlo Barbano, Antonella Trivelli, Lucia Rivabella, Rosanna Gusmano, Francesco Perfumo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We describe a child presenting with oligoclonal plasma IgM (1.2 g%) and nephrotic syndrome with focal segmental glomerulosclerosis. Oligoclonality was demonstrated by the analysis of the complementary determining region 3 (CDR 3) on immunoglobulin heavy chains and by two dimensional electrophoresis and Western blot analysis that showed the bulk of isoforms having a cationic μU chain compared with the normal homologue (pI 7.5 vs 6.5). Urinary light chains were absent, and bone marrow aspirate was normal. Usual therapies for nephrotic syndrome with steroids and cyclosporin were useless. At the age of 9 years the patient was treated with plasmapheresis plus cyclophosphamide (2 mg/kg per day for 60 days), which temporarily reduced plasma IgM, and proteinuria was normal for 3 years. After this period, due to new recurrence of nephrotic syndrome, the patient received a cycle with anti-CD20 antibodies (500 mg/m2 every week for a month) associated with a cycle of plasmapheresis that normalized proteinuria again, and, after 3 years, the proteinuria is still in remission. This is the first case of nephrotic syndrome associated with oligoclonal plasma IgM and mesangial IgM deposits. Both cyclophosphamide and anti-CD20 antibodies associated with plasmapheresis induced, at different stages, stable and protracted remission of proteinuria without evident side effects. Long term efficacy and safety of the association are still to be determined.

Original languageEnglish
Pages (from-to)1953-1956
Number of pages4
JournalPediatric Nephrology
Volume22
Issue number11
DOIs
Publication statusPublished - Nov 2007

Fingerprint

Oligoclonal Bands
Plasmapheresis
Nephrotic Syndrome
Proteinuria
Cyclophosphamide
Anti-Idiotypic Antibodies
Immunoglobulin M
Focal Segmental Glomerulosclerosis
Immunoglobulin Heavy Chains
Therapeutics
Cyclosporine
Electrophoresis
Protein Isoforms
Bone Marrow
Western Blotting
Steroids
Safety
Light
Recurrence

Keywords

  • Cationic IgM
  • Focal glomerulosclerosis
  • Mesangial proliferative glomerulonephritis
  • Nephrotic syndrome

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis. / Ghiggeri, Gian Marco; Musante, Luca; Candiano, Giovanni; Bruschi, Maurizio; Santucci, Laura; Barbano, Giancarlo; Trivelli, Antonella; Rivabella, Lucia; Gusmano, Rosanna; Perfumo, Francesco.

In: Pediatric Nephrology, Vol. 22, No. 11, 11.2007, p. 1953-1956.

Research output: Contribution to journalArticle

@article{e84d7ce405ef4284ae2db5f75a0372a1,
title = "Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis",
abstract = "We describe a child presenting with oligoclonal plasma IgM (1.2 g{\%}) and nephrotic syndrome with focal segmental glomerulosclerosis. Oligoclonality was demonstrated by the analysis of the complementary determining region 3 (CDR 3) on immunoglobulin heavy chains and by two dimensional electrophoresis and Western blot analysis that showed the bulk of isoforms having a cationic μU chain compared with the normal homologue (pI 7.5 vs 6.5). Urinary light chains were absent, and bone marrow aspirate was normal. Usual therapies for nephrotic syndrome with steroids and cyclosporin were useless. At the age of 9 years the patient was treated with plasmapheresis plus cyclophosphamide (2 mg/kg per day for 60 days), which temporarily reduced plasma IgM, and proteinuria was normal for 3 years. After this period, due to new recurrence of nephrotic syndrome, the patient received a cycle with anti-CD20 antibodies (500 mg/m2 every week for a month) associated with a cycle of plasmapheresis that normalized proteinuria again, and, after 3 years, the proteinuria is still in remission. This is the first case of nephrotic syndrome associated with oligoclonal plasma IgM and mesangial IgM deposits. Both cyclophosphamide and anti-CD20 antibodies associated with plasmapheresis induced, at different stages, stable and protracted remission of proteinuria without evident side effects. Long term efficacy and safety of the association are still to be determined.",
keywords = "Cationic IgM, Focal glomerulosclerosis, Mesangial proliferative glomerulonephritis, Nephrotic syndrome",
author = "Ghiggeri, {Gian Marco} and Luca Musante and Giovanni Candiano and Maurizio Bruschi and Laura Santucci and Giancarlo Barbano and Antonella Trivelli and Lucia Rivabella and Rosanna Gusmano and Francesco Perfumo",
year = "2007",
month = "11",
doi = "10.1007/s00467-007-0550-y",
language = "English",
volume = "22",
pages = "1953--1956",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis

AU - Ghiggeri, Gian Marco

AU - Musante, Luca

AU - Candiano, Giovanni

AU - Bruschi, Maurizio

AU - Santucci, Laura

AU - Barbano, Giancarlo

AU - Trivelli, Antonella

AU - Rivabella, Lucia

AU - Gusmano, Rosanna

AU - Perfumo, Francesco

PY - 2007/11

Y1 - 2007/11

N2 - We describe a child presenting with oligoclonal plasma IgM (1.2 g%) and nephrotic syndrome with focal segmental glomerulosclerosis. Oligoclonality was demonstrated by the analysis of the complementary determining region 3 (CDR 3) on immunoglobulin heavy chains and by two dimensional electrophoresis and Western blot analysis that showed the bulk of isoforms having a cationic μU chain compared with the normal homologue (pI 7.5 vs 6.5). Urinary light chains were absent, and bone marrow aspirate was normal. Usual therapies for nephrotic syndrome with steroids and cyclosporin were useless. At the age of 9 years the patient was treated with plasmapheresis plus cyclophosphamide (2 mg/kg per day for 60 days), which temporarily reduced plasma IgM, and proteinuria was normal for 3 years. After this period, due to new recurrence of nephrotic syndrome, the patient received a cycle with anti-CD20 antibodies (500 mg/m2 every week for a month) associated with a cycle of plasmapheresis that normalized proteinuria again, and, after 3 years, the proteinuria is still in remission. This is the first case of nephrotic syndrome associated with oligoclonal plasma IgM and mesangial IgM deposits. Both cyclophosphamide and anti-CD20 antibodies associated with plasmapheresis induced, at different stages, stable and protracted remission of proteinuria without evident side effects. Long term efficacy and safety of the association are still to be determined.

AB - We describe a child presenting with oligoclonal plasma IgM (1.2 g%) and nephrotic syndrome with focal segmental glomerulosclerosis. Oligoclonality was demonstrated by the analysis of the complementary determining region 3 (CDR 3) on immunoglobulin heavy chains and by two dimensional electrophoresis and Western blot analysis that showed the bulk of isoforms having a cationic μU chain compared with the normal homologue (pI 7.5 vs 6.5). Urinary light chains were absent, and bone marrow aspirate was normal. Usual therapies for nephrotic syndrome with steroids and cyclosporin were useless. At the age of 9 years the patient was treated with plasmapheresis plus cyclophosphamide (2 mg/kg per day for 60 days), which temporarily reduced plasma IgM, and proteinuria was normal for 3 years. After this period, due to new recurrence of nephrotic syndrome, the patient received a cycle with anti-CD20 antibodies (500 mg/m2 every week for a month) associated with a cycle of plasmapheresis that normalized proteinuria again, and, after 3 years, the proteinuria is still in remission. This is the first case of nephrotic syndrome associated with oligoclonal plasma IgM and mesangial IgM deposits. Both cyclophosphamide and anti-CD20 antibodies associated with plasmapheresis induced, at different stages, stable and protracted remission of proteinuria without evident side effects. Long term efficacy and safety of the association are still to be determined.

KW - Cationic IgM

KW - Focal glomerulosclerosis

KW - Mesangial proliferative glomerulonephritis

KW - Nephrotic syndrome

UR - http://www.scopus.com/inward/record.url?scp=34848834772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848834772&partnerID=8YFLogxK

U2 - 10.1007/s00467-007-0550-y

DO - 10.1007/s00467-007-0550-y

M3 - Article

C2 - 17661091

AN - SCOPUS:34848834772

VL - 22

SP - 1953

EP - 1956

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 11

ER -